methyl 3-(1-(5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-((dimethylamino)methyl)piperidine-4-carboxamido)benzoate

ID: ALA3613623

Chembl Id: CHEMBL3613623

PubChem CID: 122189176

Max Phase: Preclinical

Molecular Formula: C25H32N6O3

Molecular Weight: 464.57

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]c(C)c(C)c34)CC2)c1

Standard InChI:  InChI=1S/C25H32N6O3/c1-16-17(2)28-21-20(16)22(27-15-26-21)31-11-9-25(10-12-31,14-30(3)4)24(33)29-19-8-6-7-18(13-19)23(32)34-5/h6-8,13,15H,9-12,14H2,1-5H3,(H,29,33)(H,26,27,28)

Standard InChI Key:  RKAKGPYRNHXPDK-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA3613623

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 464.57

Molecular Weight (Monoisotopic): 464.2536

AlogP: 3.15

#Rotatable Bonds: 6

Polar Surface Area: 103.45

Molecular Species: BASE

HBA: 7

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.40

CX Basic pKa: 9.74

CX LogP: 3.43

CX LogD: 1.09

Aromatic Rings: 3

Heavy Atoms: 34

QED Weighted: 0.54

Np Likeness Score: -1.11

References

1. Boland S, Bourin A, Alen J, Geraets J, Schroeders P, Castermans K, Kindt N, Boumans N, Panitti L, Vanormelingen J, Fransen S, Van de Velde S, Defert O..  (2015)  Design, synthesis and biological characterization of selective LIMK inhibitors.,  25  (18): [PMID:26233434] [10.1016/j.bmcl.2015.07.009]

2. Manetti F..  (2018)  Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials.,  155  [PMID:29908439] [10.1016/j.ejmech.2018.06.016]

Source

Source(1):

• Scientific Literature